Clinical Trial Update: Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating denosumab for metabolic bone disease in chronic intestinal failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Bone Disease

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Stanley Dudrick's Memorial Hospital | Conditions: Metabolic Bone Disease | Phase 4 | Status: COMPLETED